RAPT Therapeutics Inc Financial Flexibility Index
RAPT Therapeutics Inc financial flexibility index. RAPT Therapeutics Inc (RAPT) has a Financial Flexibility Index of -0.91x as of September 2025. Free cash flow of $-12.46 Million (operating CF $-12.46 Million minus capex $0.00) represents -1% of total liabilities ($13.76 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of RAPT Therapeutics Inc (2017–2024)
Financial flexibility index of RAPT Therapeutics Inc from 2017 to 2024. Historical Financial Flexibility Index trend for RAPT Therapeutics Inc across 8 annual periods. Explore debt repayment capacity of RAPT Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
RAPT Therapeutics Inc Financial Flexibility Index by Year (2017–2024)
RAPT Therapeutics Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for RAPT Therapeutics Inc. For the full cash flow conversion analysis, see RAPT Therapeutics Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.65x | $-83.17 Million | $-83.30 Million | $50.42 Million | ▲ +54.8% |
| 2023 | -3.65x | $-95.92 Million | $-97.05 Million | $26.29 Million | ▼ -9.8% |
| 2022 | -3.32x | $-69.93 Million | $-70.77 Million | $21.04 Million | ▲ +32.4% |
| 2021 | -4.92x | $-60.27 Million | $-61.03 Million | $12.26 Million | ▼ -81.4% |
| 2020 | -2.71x | $-40.09 Million | $-40.49 Million | $14.79 Million | ▲ +10.0% |
| 2019 | -3.01x | $-34.59 Million | $-35.47 Million | $11.48 Million | ▲ +42.6% |
| 2018 | -5.25x | $-29.45 Million | $-32.95 Million | $5.61 Million | ▼ -2176.9% |
| 2017 | -0.23x | $-26.00 Million | $-27.12 Million | $112.80 Million | — |